Alvotech Files 6-K for June 30, 2024 Period
Ticker: ALVOW · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
TL;DR
Alvotech dropped a 6-K for Q2 2024, mostly standard filings for foreign issuers.
AI Summary
Alvotech filed a Form 6-K on August 15, 2024, for the period ending June 30, 2024. The report is a filing by a foreign private issuer and includes information incorporated by reference into their registration statements on Form F-3. The company is based in Luxembourg and operates in the biological products sector.
Why It Matters
This filing provides updated information for investors regarding Alvotech's financial reporting and regulatory compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information that would immediately impact risk.
Key Numbers
- 001-41421 — SEC File Number (Alvotech's SEC filing identifier)
Key Players & Entities
- Alvotech (company) — Registrant
- 0001628280-24-037389 (filing_id) — Accession Number
- 20240630 (date) — Conformed Period of Report
- 20240815 (date) — Filed as of Date
- Luxembourg (location) — Company Headquarters
- Form 6-K (document_type) — Filing Type
- Form 20-F (document_type) — Annual Report Cover
- Form F-3 (document_type) — Registration Statement
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 for the month of August 2024, for Alvotech as a foreign private issuer.
What period does this report cover?
This report covers the period ending June 30, 2024.
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What type of annual report does Alvotech file?
Alvotech files its annual reports under cover of Form 20-F.
What is Alvotech's SIC code and industry?
Alvotech's Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (no diagnostic substances).
Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2024-08-15 16:10:50
Filing Documents
- alvo-20240630_d2.htm (6-K) — 24KB
- alvo-20240630.htm (EX-99.1) — 949KB
- alvotechq22024-mda.htm (EX-99.2) — 239KB
- earningsreleaseq22024notab.htm (EX-99.3) — 61KB
- image_0.jpg (GRAPHIC) — 20KB
- 0001628280-24-037389.txt ( ) — 7328KB
- alvo-20240630.xsd (EX-101.SCH) — 88KB
- alvo-20240630_cal.xml (EX-101.CAL) — 82KB
- alvo-20240630_def.xml (EX-101.DEF) — 310KB
- alvo-20240630_lab.xml (EX-101.LAB) — 687KB
- alvo-20240630_pre.xml (EX-101.PRE) — 516KB
- alvo-20240630_d2_htm.xml (XML) — 1051KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations. 99.3 Earnings Release for the six months ended June 30, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ALVOTECH Date: August 15, 2024 By: /s/ Tanya Zharov Name: Tanya Zharov Title: General Counsel